COMP and neoplasm: In a xenograft mouse model, the co-injection of COMP-expressing CAFs at a 3 to 1 ratio with SKOV3 cells demonstrated a remarkable escalation in tumor volumes in comparison to the co-injection of mock-transfected CAFs with SKOV3 cells (Fig. 1E).